Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2026-01-17 @ 12:53 AM
Study NCT ID:
NCT02641093
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-08-29
First Post:
2015-12-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma
Sponsor:
Trisha Wise-Draper
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-11-02
Completion Date Type:
ESTIMATED
First Submit Date:
2015-12-21
First Submit QC Date:
None
Study First Post Date:
2015-12-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-01-31
Results First Submit QC Date:
None
Results First Post Date:
2023-05-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-27
Last Update Post Date:
2024-08-29
Last Update Post Date Type:
ACTUAL